Market cap
$31.2M

Nasus Pharma Ltd. (NSRX) is a Biotechnology: Pharmaceutical Preparations company listed on AMEX. In the last 30 days Quantisnow tracked 7 wire items for NSRX, including 2 SEC filings, 2 insider trades and 1 press release or news item. The most recent was published Nov 16, 2026.

Financial highlights

Full financials
Revenue, FY2025
$1.24B
Net income, FY2025
-$5.86M
Net margin
-0.5%
Free cash flow, FY2025
-$4.93M
Cash
$1.24M

For fiscal 2025 (ended Dec 31, 2025), from SEC filings. Not investment advice.

News · 26 weeks37+100%
2026-05-24: 12026-05-31: 12026-06-07: 22026-06-14: 02026-06-21: 42026-06-28: 02026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 42026-08-02: 02026-08-09: 12026-08-16: 52026-08-23: 02026-08-30: 22026-09-06: 12026-09-13: 52026-09-20: 22026-09-27: 12026-10-04: 12026-10-11: 02026-10-18: 12026-10-25: 02026-11-01: 02026-11-08: 22026-11-15: 4
2026-05-242026-11-15
Mix2290d
  • SEC Filings10(45%)
  • Other6(27%)
  • Insider4(18%)
  • 13D/G1(5%)
  • Leadership1(5%)
Activity · 52 weeks7951 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

NSRX FAQ

9 questions
  • What is the latest news on NSRX?
    In the last 30 days Quantisnow tracked 7 wire items for NSRX: 2 SEC filings, 2 insider trades, 1 press release or news item and 1 13D/G filing. The most recent was published on November 16, 2026.
  • What is NSRX revenue?
    Nasus Pharma Ltd. (NSRX) reported $1.24B of revenue for fiscal 2025 (ended Dec 31, 2025).
  • Is NSRX profitable?
    No. Nasus Pharma Ltd. reported a net loss of $5.86M for fiscal 2025 (ended Dec 31, 2025).
  • How much cash and debt does NSRX have?
    Nasus Pharma Ltd. reported $1.24M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does NSRX stock trade?
    Nasus Pharma Ltd. (NSRX) is listed on AMEX.
  • What sector and industry is NSRX in?
    Nasus Pharma Ltd. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Nasus Pharma Ltd. go public?
    Nasus Pharma Ltd. (NSRX) completed its IPO in 2025.
  • What companies are similar to NSRX?
    Notable peers in the same industry include ABT (Abbott Laboratories), JNJ (Johnson & Johnson), MRK (Merck & Company Inc.), NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC). Compare NSRX side-by-side with any of them on Quantisnow.
  • How can I track NSRX on Quantisnow?
    Quantisnow aggregates Nasus Pharma Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NSRX to receive live email and push alerts on every new disclosure.